Follow
Jatinder Josan
Jatinder Josan
Assistant Professor of Chemistry, Virginia Tech
Verified email at vt.edu - Homepage
Title
Cited by
Cited by
Year
Heterobivalent Ligands Crosslink Multiple Cell‐Surface Receptors: The human melanocortin‐4 and δ‐opioid receptors
J Vagner, L Xu, HL Handl, JS Josan, DL Morse, EA Mash, RJ Gillies, ...
Angewandte Chemie 120 (9), 1709-1712, 2008
902008
Heterobivalent ligands target cell-surface receptor combinations in vivo
L Xu, JS Josan, J Vagner, MR Caplan, VJ Hruby, EA Mash, RM Lynch, ...
Proceedings of the National Academy of Sciences 109 (52), 21295-21300, 2012
832012
Synthesis and evaluation of bivalent NDP-α-MSH (7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R)
HL Handl, R Sankaranarayanan, JS Josan, J Vagner, EA Mash, RJ Gillies, ...
Bioconjugate chemistry 18 (4), 1101-1109, 2007
802007
Enhanced targeting with heterobivalent ligands
L Xu, J Vagner, J Josan, RM Lynch, DL Morse, B Baggett, H Han, ...
Molecular cancer therapeutics 8 (8), 2356-2365, 2009
682009
Cell-specific targeting by heterobivalent ligands
JS Josan, HL Handl, R Sankaranarayanan, L Xu, RM Lynch, J Vagner, ...
Bioconjugate chemistry 22 (7), 1270-1278, 2011
652011
Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand
NM Barkey, NK Tafreshi, JS Josan, CR De Silva, KN Sill, VJ Hruby, ...
Journal of medicinal chemistry 54 (23), 8078-8084, 2011
622011
Solid-phase synthesis of heterobivalent ligands targeted to melanocortin and cholecystokinin receptors
JS Josan, J Vagner, HL Handl, R Sankaranarayanan, RJ Gillies, VJ Hruby
International journal of peptide research and therapeutics 14 (4), 293-300, 2008
422008
MMTV-PyMT and derived Met-1 mouse mammary tumor cells as models for studying the role of the androgen receptor in triple-negative breast cancer progression
JL Christenson, KT Butterfield, NS Spoelstra, JD Norris, JS Josan, ...
Hormones and Cancer 8 (2), 69-77, 2017
392017
Predictive features of ligand‐specific signaling through the estrogen receptor
JC Nwachukwu, S Srinivasan, Y Zheng, S Wang, J Min, C Dong, Z Liao, ...
Molecular systems biology 12 (4), 864, 2016
362016
Solid-Phase Synthetic Strategy and Bioevaluation of a Labeled δ-Opioid Receptor Ligand Dmt-Tic-Lys for In Vivo Imaging
JS Josan, DL Morse, L Xu, M Trissal, B Baggett, P Davis, J Vagner, ...
Organic letters 11 (12), 2479-2482, 2009
332009
Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues
R Jain, J Singh, JH Perlman, MC Gershengorn
Bioorganic & medicinal chemistry 10 (1), 189-194, 2002
302002
Fluorescent and lanthanide labeling for ligand screens, assays, and imaging
JS Josan, CRD Silva, B Yoo, RM Lynch, MD Pagel, J Vagner, VJ Hruby
Drug Design and Discovery, 89-126, 2011
292011
Resazurin live cell assay: Setup and fine-tuning for reliable cytotoxicity results
JÁ Rodríguez-Corrales, JS Josan
Proteomics for Drug Discovery, 207-219, 2017
202017
Synthesis, receptor binding, and activation studies of N (1)-alkyl-L-histidine containing thyrotropin-releasing hormone (TRH) analogues
N Kaur, V Monga, JS Josan, X Lu, MC Gershengorn, R Jain
Bioorganic & medicinal chemistry 14 (17), 5981-5988, 2006
202006
Tumor targeting and pharmacokinetics of a near-Infrared fluorescent-labeled δ-opioid receptor antagonist agent, Dmt-Tic-Cy5
AS Huynh, V Estrella, VE Stark, AS Cohen, T Chen, TJ Casagni, JS Josan, ...
Molecular pharmaceutics 13 (2), 534-544, 2016
142016
Cancer: Designer antiandrogens join the race against drug resistance
JS Josan, JA Katzenellenbogen
Elife 2, e00692, 2013
82013
Heterobivalent ligands crosslink multiple cell-surface receptors—a step towards personal medicine
JS Josan, R Sankaranarayanan, HL Hand, S Fernandes, L Xu, J Vagner, ...
Peptides for Youth, 413-414, 2009
42009
Separation of stereoisomers of 7-oxa-bicyclo [2.2. 1] heptene sulfonate (obhs), a selective estrogen receptor modulator (serm), via chiral stationary phases using sfc/uv and sfc/ms
P Balasubramanyam, M Ashraf-Khorassani, JS Josan
Journal of Chromatography B 1092, 279-285, 2018
32018
Heteromultivalent ligands directed targeting of cell-surface receptors—Implications in cancer diagnostics & therapeutics
JS Josan
The University of Arizona, 2008
32008
New approaches to the design, synthesis and biochemical and biophysical evaluation of heteromultivalent ligands for detection and treatment of cancer
V Hruby, J Josan, J Vagner, S Fernandes, H Handl, L Xu, L Ronald, ...
Journal of Peptide Science 14 (8), 23-23, 2008
22008
The system can't perform the operation now. Try again later.
Articles 1–20